Zinc DeficiencyPhase 4NCT00944398
Impact of Targeted Zinc Fortification Programs on Plasma Zinc Concentration
A Phase 4 study testing Zinc fortified food, Zinc supplement and Non-fortified food in people with Zinc Deficiency, run by University of California, Davis at 1 site in Senegal.
Trial summary
The purpose of the study is to evaluate the use of plasma zinc concentration for assessing the impact of targeted zinc fortification programs. Read more about this study
- Who is it for?
- Ages 12 to 17 monthsHealthy volunteers can take part
- Conditions the study is for
- Zinc Deficiency
- What is being tested?
- Zinc fortified food, Zinc supplement and Non-fortified food
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 98 participants
- Where
- 1 siteSenegal
- Study dates
- Jan 2009to Oct 2009
- Phase
- Phase 4
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 12 to 17 months
- All sexes
- Healthy volunteers accepted
- Child
Who may be able to join
- apparently healthy
Who cannot join
- severe malnutrition
- severe anemia
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Evaluation of the Use of Plasma Zinc Concentration for Assessing the Impact of Targeted and Mass Zinc Fortification Programs
The purpose of the study is to evaluate the use of plasma zinc concentration for assessing the impact of targeted zinc fortification programs.
Read the detailed description
The objectives of the present study are to determine whether plasma zinc concentration changes in response to additional zinc consumption, as provided by zinc-fortified cereal-based complementary foods fed to young children. The following specific steps will be completed:
- Zinc-fortified complementary foods and breads prepared from zinc-fortified cereal flours will be developed with assistance from experts in food technology.
- A two-week feeding trial will be implemented to assess the change in plasma zinc concentration among young children who receive: a) the zinc-fortified cereal porridge and a liquid vitamin preparation between meals; b) a non-zinc-fortified cereal porridge and a liquid vitamin preparation between meals [negative control group]; or c) a non-zinc-fortified cereal porridge and a zinc-containing liquid vitamin preparation between meals [positive control group].
- Conditions
- Zinc Deficiency
- Being tested
- Zinc fortified food, Zinc supplement, Placebo supplement, Non-fortified food
- Keywords
- Zinc fortification, Plasma zinc concentration, Assessment of zinc status
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Zinc fortified foodDietary supplement
Also called Provital, CoAID
Daily consumption
Zinc supplementDietary supplement
Also called Zinc sulfate and B vitamins, DSM
Liquid supplement containing zinc sulfate
Placebo supplementOther
Also called B vitamins, DSM
Liquid placebo supplement
Non-fortified foodDietary supplement
Also called Provital, CoAID
Non-fortified complementary food.
| Study group | Role | What they receive |
|---|---|---|
| Zinc fortified group | Experimental | Daily consumption of zinc-fortified complementary food Receives: Dietary Supplement: Zinc fortified food; Other: Placebo supplement |
| Non-fortified group | Placebo comparator | Daily consumption of non-fortified complementary food and placebo supplement. Receives: Other: Placebo supplement; Dietary Supplement: Non-fortified food |
| Zinc supplement group | Experimental | Daily consumption of zinc supplement and non-fortified complementary food. Receives: Dietary Supplement: Zinc supplement; Dietary Supplement: Non-fortified food |
What is being measured
The primary outcome is the main question the study is designed to answer.
Plasma zinc concentration
Measured: 3 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Jul 2009 (estimated)
- Study startJan 2009
- Primary completionSep 2009
- Study completionOct 2009
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Zinc DeficiencyStudies of the same condition, open and under way.
- More trials run by University of California, DavisThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 4
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind
- Who is masked
- Participant, Care provider, Investigator, Outcomes assessor
- Enrolment
- 98 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of California, Davis
- Sponsor type
- University, hospital or other
- Collaborators
- Helen Keller International, Cheikh Anta Diop University, Senegal, Global Alliance for Improved Nutrition
- Investigators
- Kenneth H Brown, MD, Principal investigator, University of California, Davis
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00944398
- Sponsor's protocol ID
- 200817275
- Other IDs
- 107008
- Status last verified
- Feb 2010
- First submitted
- 21 Jul 2009
- Last updated
- 19 Feb 2010
- Results posted
- No
- Data monitoring committee
- No
Publications
Lo NB, Aaron GJ, Hess SY, Dossou NI, Guiro AT, Wade S, Brown KH. Plasma zinc concentration responds to short-term zinc supplementation, but not zinc fortification, in young children in Senegal1,2. Am J Clin Nutr. 2011 Jun;93(6):1348-55. doi: 10.3945/ajcn.111.012278. Epub 2011 Apr 13.
PubMed 21490143
Study at a glance
From the registry record, last updated by the sponsor on 19 Feb 2010. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of the Use of Plasma Zinc Concentration for Assessing the Impact of Targeted and Mass Zinc Fortification Programs
- ClinicalTrials.gov ID
- NCT00944398
- Acronym / sponsor ID
- 200817275
- Conditions
- Zinc Deficiency
- Keywords
- Zinc fortification, Plasma zinc concentration, Assessment of zinc status
- Phase
- Phase 4
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 98 participants (actual)
- Lead sponsor
- University of California, DavisUniversity, hospital or other
- Collaborators
- Helen Keller International, Cheikh Anta Diop University, Senegal, Global Alliance for Improved Nutrition
- Study start
- Jan 2009
- Primary completion
- Sep 2009 (actual)
- Study completion
- Oct 2009 (actual)
- First posted
- 23 Jul 2009 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of the study is to evaluate the use of plasma zinc concentration for assessing the impact of targeted zinc fortification programs.
Detailed description
The objectives of the present study are to determine whether plasma zinc concentration changes in response to additional zinc consumption, as provided by zinc-fortified cereal-based complementary foods fed to young children. The following specific steps will be completed:
- Zinc-fortified complementary foods and breads prepared from zinc-fortified cereal flours will be developed with assistance from experts in food technology.
- A two-week feeding trial will be implemented to assess the change in plasma zinc concentration among young children who receive: a) the zinc-fortified cereal porridge and a liquid vitamin preparation between meals; b) a non-zinc-fortified cereal porridge and a liquid vitamin preparation between meals [negative control group]; or c) a non-zinc-fortified cereal porridge and a zinc-containing liquid vitamin preparation between meals [positive control group].
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind (participant, care provider, investigator, outcomes assessor)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Zinc fortified group | Experimental | Dietary Supplement: Zinc fortified food, Other: Placebo supplementDaily consumption of zinc-fortified complementary food |
| Non-fortified group | Placebo comparator | Other: Placebo supplement, Dietary Supplement: Non-fortified foodDaily consumption of non-fortified complementary food and placebo supplement. |
| Zinc supplement group | Experimental | Dietary Supplement: Zinc supplement, Dietary Supplement: Non-fortified foodDaily consumption of zinc supplement and non-fortified complementary food. |
Who may qualify
- Ages
- 12 to 17 months
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
Key inclusion criteria (1 listed)
- apparently healthy
Key exclusion criteria (2 listed)
- severe malnutrition
- severe anemia
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Zinc fortified foodAlso: Provital, CoAIDDaily consumption | Dietary supplement | Zinc fortified group |
| Zinc supplementAlso: Zinc sulfate and B vitamins, DSMLiquid supplement containing zinc sulfate | Dietary supplement | Zinc supplement group |
| Placebo supplementAlso: B vitamins, DSMLiquid placebo supplement | Other | Non-fortified group, Zinc fortified group |
| Non-fortified foodAlso: Provital, CoAIDNon-fortified complementary food. | Dietary supplement | Non-fortified group, Zinc supplement group |
Primary outcome
Plasma zinc concentration
Time frame: 3 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Feb 2010.
- Derived from this study: PubMed 21490143Lo NB, Aaron GJ, Hess SY, Dossou NI, Guiro AT, Wade S, Brown KH. Plasma zinc concentration responds to short-term zinc supplementation, but not zinc fortification, in young children in Senegal1,2. Am J Clin Nutr. 2011 Jun;93(6):1348-55. doi: 10.3945/ajcn.111.012278. Epub 2011 Apr 13.
Related trials for Zinc Deficiency
Active, not recruitingPhase 1
Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected Patients
HIV
Active, not recruitingPhase 1
CD4 CAR+ ZFN-modified T Cells in HIV Therapy
Hiv
Recruiting
Zn Supplementation in HIV Immunological Non Responders
HIV, Zinc Status
Recruiting
Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc
Zinc Deficiency, Inflammation
RecruitingObservational study
Non-invasive Detection of Iron Deficiency in Obstetrics
Iron Deficiency Anemia of Pregnancy, Iron-deficiency
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Kenneth H Brown, MD principal investigator
University of California, Davis
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 4 study testing Zinc fortified food, Zinc supplement and Non-fortified food in people with Zinc Deficiency, run by University of California, Davis at 1 site in Senegal.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 Feb 2010. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Senegal. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Plasma zinc concentration (time frame: 3 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT00944398, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Feb 2010.